Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188272 Fused heterocyclic compounds useful as kinase modulators
05/29/2012US8188271 Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
05/29/2012US8188270 Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
05/29/2012US8188266 Cellulose- or lignocellulose-containing composite materials based on a silane-based composite as a binder
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188247 Conjugates and compositions for cellular delivery
05/29/2012US8188222 High molecular weight derivative of nucleic acid antimetabolite
05/29/2012US8188151 Methods for treating diabetes
05/29/2012US8188150 Use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
05/29/2012US8188149 Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
05/29/2012US8188148 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
05/29/2012US8188147 Administering a urea cycle intermediate, citrulline; preventing hyperammonemia
05/29/2012US8188146 Highly purified ethyl EPA and other EPA derivatives
05/29/2012US8188145 Synthetic lactone formulations and method of use
05/29/2012US8188144 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
05/29/2012US8188143 Pharmaceutical composition useful as acetylcholinesterase inhibitors
05/29/2012US8188142 Polymers from propenyl ether monomers
05/29/2012US8188141 Isomigrastatin analogs in the treatment of cancer
05/29/2012US8188140 Uses of ion channel modulating compounds
05/29/2012US8188139 Heterocyclic-substituted phenyl methanones
05/29/2012US8188138 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
05/29/2012US8188137 HCV protease inhibitors and uses thereof
05/29/2012US8188135 Compounds as cannabinoid receptor ligands
05/29/2012US8188134 Thiophene-carboxamides useful as inhibitors of protein kinases
05/29/2012US8188133 Imidazole derivatives, preparation and user thereof as medicine
05/29/2012US8188132 Linked dibenzimidazole derivatives
05/29/2012US8188131 Compounds that enhance Atoh1 expression
05/29/2012US8188130 Anti-cancer hydantoin compounds and methods
05/29/2012US8188128 Opioid receptor subtype-selective agents
05/29/2012US8188126 Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
05/29/2012US8188125 Human protein tyrosine phosphatase inhibitors and methods of use
05/29/2012US8188124 Talarazole metabolites
05/29/2012US8188123 (Pyrrolidin-2-yl)phenyl derivatives
05/29/2012US8188121 Substituted pyridines as antiparasitic AZA teraryl compounds
05/29/2012US8188120 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/29/2012US8188119 Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
05/29/2012US8188118 Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
05/29/2012US8188117 Piperidinyl-substituted isoquinolone derivatives
05/29/2012US8188116 Ligand/drug conjugates; near infrared radiation imaging; peripheral benzodiazepine receptor imaging; drug delivery; drug targets; cancer, metastasis
05/29/2012US8188115 5-HT7 receptor antagonists
05/29/2012US8188114 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof
05/29/2012US8188113 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
05/29/2012US8188112 Naphthalamide derivatives having antiproliferative activity
05/29/2012US8188111 Amide and carbamate derivatives of alkyl substituted N-[4-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)butyI]methanesulfonamides and methods
05/29/2012US8188110 Morphinan compounds
05/29/2012US8188109 Benzoquinolizinium salt derivatives as anticancer agents
05/29/2012US8188108 Pharmaceutical composition
05/29/2012US8188107 T-614 is a cyclooxygenase-2 inhibitor; reduced plasma concentrations of an opioid analgesic, while still providing effective pain management; side effect reduction
05/29/2012US8188106 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
05/29/2012US8188105 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
05/29/2012US8188104 Anti-infective agents and uses thereof
05/29/2012US8188103 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
05/29/2012US8188102 Amide derivative for inhibiting the growth of cancer cells
05/29/2012US8188101 Dihydropyridopyrimidines for the treatment of AB-related pathologies
05/29/2012US8188100 Adenosine derivatives as A2A receptor agonists
05/29/2012US8188099 Method of decreasing hepatotoxic side effects using A2B adenosine receptor antagonists
05/29/2012US8188098 GPR119 receptor agonists
05/29/2012US8188097 Pyrazolo[1,5-A]pyrimidine compounds
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012US8188094 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
05/29/2012US8188093 Pyrazinecarboxamide derivatives as HDL-cholesterol raising agents
05/29/2012US8188092 Substituted pyrazines as DGAT-1 inhibitors
05/29/2012US8188091 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
05/29/2012US8188090 Naphthylacetic acids
05/29/2012US8188089 Tylophorine analogs as antitumor agents
05/29/2012US8188088 Ethenyl carboxamide derivatives useful as microbiocides
05/29/2012US8188087 Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl) piperazin-1-yl]methanone phosphate
05/29/2012US8188086 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
05/29/2012US8188085 Antifungal agents
05/29/2012US8188083 Triazolopyridazines
05/29/2012US8188082 5,6,7,8-tetrahydro-imidazo[1,5-α]pyrazine derivatives
05/29/2012US8188081 Methods of treating inflammation using prokineticin 1 receptor antagonists
05/29/2012US8188080 VHR protein tyrosine phosphatase inhibitors, compositions and methods of use
05/29/2012US8188079 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
05/29/2012US8188078 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inhibitors
05/29/2012US8188077 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/29/2012US8188076 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
05/29/2012US8188075 Triazole compounds that modulate HSP90 activity
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8188073 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
05/29/2012US8188072 Benzodiazepinone compounds useful in the treatment of skin conditions
05/29/2012US8188071 Amino substituted pyridines as potent kinase inhibitors
05/29/2012US8188070 Method of treating neurological diseases and disorders
05/29/2012US8188069 Azepine derivatives as gamma-secretase inhibitors
05/29/2012US8188068 Bridged polycyclic compound based compositions for coating oral surfaces in pets
05/29/2012US8188067 Formulations of 6-mercaptopurine
05/29/2012US8188066 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
05/29/2012US8188065 Boldine compounds for promoting bone growth
05/29/2012US8188064 Reducing cell differentiation of adipocyte; reducing body fat
05/29/2012US8188063 A2A receptor agonists for the central nervous system; antiinflammatory agents; 2,7-disubstituted-5-amino-pyrazolo[4,3-e]-[1,2,4]-triazolo[1,5-c]pyrimidines, mefloquine, 8-(3-chlorostyryl)caffeine, 3,7,8-trisubstituted-1-propargyl-xanthines; 2,5-disubstituted-7-amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines
05/29/2012US8188062 Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
05/29/2012US8188061 RNAi modulation of APOB and uses thereof
05/29/2012US8188059 Compounds and methods for modulating expression of GCGR
05/29/2012US8188058 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
05/29/2012US8188056 Utilizing nucleic acid expression constructs that are delivered into a subject and express stable therapeutic proteins in vivo
05/29/2012US8188055 Inactivators of O6-alkylguanine-DNA alkyltransferase
05/29/2012US8188054 Non-peptide macrocyclic histone deacetylase (HDAC) inhibitors and methods of making and using thereof
05/29/2012US8188047 Therapeutic and cosmetic compositions for treatment of skin
05/29/2012US8188008 Herbicidally and insecticidally active 4-phenyl-substituted pyridazinones
1 ... 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 ... 7860